Enlitic, Inc. (ASX:ENL)

Market Cap	4.17M -86.8%
Revenue (ttm)	5.61M +251.9%
Net Income	-19.43M
EPS	-0.02
Shares Out	833.18M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,225,884
Open	0.0050
Previous Close	0.0050
Day's Range	0.0040 - 0.0050
52-Week Range	0.0030 - 0.0450
Beta	-0.45
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 27, 2026

About Enlitic

Enlitic, Inc. operates in the healthcare sector in the United States, Europe, and Japan. The company uses artificial intelligence (AI) to develop software products that manage medical imaging data in radiology, such as magnetic resonance imaging, computed tomography scans, X-ray, and ultrasound images. Its healthcare data solutions include ENDEX, a platform that uses AI to standardize new and historical medical image data descriptions; ENCOG, an AI enabled data anonymization solution designed to de-identify protected health information from med...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2014
• Country: United States
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: ENL

Financial Performance

In 2025, Enlitic's revenue was $3.80 million, an increase of 251.87% compared to the previous year's $1.08 million. Losses were -$13.37 million, -12.23% less than in 2024.

Financial numbers in USD

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 20, 2026

Data Sources Report a data error